Mena Food Group
Outcome
FDA issued a warning letter dated August 8, 2024, after a November 2023–November 2023 inspection of Mena Food Group found the company failed to implement preventive controls for Salmonella and Listeria monocytogenes in ready-to-eat products during post-baking stages, violating 21 CFR Part 117 CGMP and preventive controls requirements.
Details
Mena Food Group — Salmonella / Listeria Preventive Controls Failure / FDA Warning Letter (2024)
Outcome: FDA issued a warning letter dated August 8, 2024, following an inspection from October 30–November 20, 2023, citing Mena Food Group for failing to implement adequate preventive controls for Salmonella and Listeria monocytogenes at the post-baking stages of its ready-to-eat product manufacturing — violating the FSMA Preventive Controls for Human Food rule (21 CFR Part 117).
Mena Food Group produces ready-to-eat baked goods and food products. FDA investigators inspected the firm's facility from October 30 to November 20, 2023, and found serious violations of the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food regulation. The warning letter was issued on August 8, 2024 — approximately nine months after the inspection concluded — which reflects FDA's typical review timeline for complex FSMA enforcement actions.
The violations centered on the firm's failure to identify and control pathogen hazards at the post-baking stages of production. For ready-to-eat baked products, the baking step (if validated at sufficient temperature and time) constitutes a kill step for Salmonella and Listeria. However, post-baking operations — including cooling conveyors, slicers, packaging equipment, and the hands of workers handling finished product — represent critical environmental contamination points where reintroduction of pathogens can occur. The firm's food safety plan either lacked adequate preventive controls for these post-baking hazard points or failed to verify and validate that those controls were operating effectively.
The warning letter also cited food safety labeling failures in connection with the product line. Absent a voluntary recall, the FDA warning letter requires a written response within 15 working days documenting corrective actions.
Primary Source: FDA Warning Letters Index | FDA
How Crucible Prevents This
Post-baking contamination in RTE bakery products occurs at the cooling, slicing, and packaging stages — process steps where environmental Listeria and Salmonella controls must be explicitly documented in the food safety plan. Crucible's DECISIONS log would require the firm to document, at each production run, that post-baking environmental monitoring results were reviewed and controls were verified effective. The CGMP and preventive controls violations found by FDA indicate the food safety plan either lacked post-baking controls or lacked any verification that they were working.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works